Stay updated on Pembrolizumab and Epacadostat in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe government funding status banner was removed from the page; the study history table and links remain unchanged.SummaryDifference0.6%

- Check33 days agoChange DetectedThe new screenshot shows a minor visual refresh of the Record History page (slightly different header/footer styling) with no additions or removals in the version list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference11%

- Check69 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top link was removed.SummaryDifference0.7%

Stay in the know with updates to Pembrolizumab and Epacadostat in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.